Philippe B.
- Country
- France
- Department
- Department of pulmonology and respiratory intensive care
Research Overview
- Assessment of 18F-Fluoromisonidazole PET Hypoxia Imaging in Idiopathic Pulmonary Fibrosis: A Non-Randomized Proof-of-Concept Study
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 244 of 484 partner sites.
Specializations
Respiratory Infections
This investigator specializes in treating complex respiratory infections, particularly focusing on Mycobacterium avium complex and Mycobacterium xenopi pulmonary infections. Their work extends to chronic pulmonary aspergillosis management using innovative therapeutic approaches.
- Mycobacterial Disease Treatment
- Fungal Respiratory Infections
- Antimicrobial Therapy Optimization
Interstitial Lung Diseases
The investigator focuses on advancing treatments for various forms of interstitial lung disease, with particular emphasis on idiopathic pulmonary fibrosis and systemic sclerosis-related ILD. Their research encompasses innovative therapeutic approaches using both established and novel medications.
- Progressive Pulmonary Fibrosis
- Autoimmune-Related Lung Disease
- Fibrotic Lung Disease Management
Severe Asthma Management
The investigator specializes in treating severe asthma with particular focus on eosinophilic phenotypes and allergic asthma. Their expertise includes evaluation of biological therapies and assessment of treatment responses in difficult-to-treat cases.
- Biological Therapy Assessment
- Treatment Response Prediction
- Asthma Phenotype Analysis
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.